Trabectedin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Trabectedin. Educational only — not medical advice.
Labeled uses
YONDELIS ® is indicated for the treatment of adult patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen [see Clinical Studies (14) ] .
Source: FDA labeling via NIH DailyMed (set 472bd78e…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.